BETHLEHEM, Pa. -- B. Braun Medical Inc. announced today
that Premier, the nationwide alliance of over 1,500 hospitals and health
systems, selected B. Braun Medical for a full-line, dual-source infusion
contract. The five-year contract valued at $750 million annually is
effective February 1, 2004 and encompasses all major B. Braun Medical
product lines including B. Braun's key safety products.
Through this new contract, Premier members will have access to B. Braun's
award-winning, safety-engineered infusion products including the Outlook(tm)
Safety Infusion System, Introcan Safety* IV Catheter, ULTRASITE* Needle-Free
IV System, Excel* PVC-Free/DEHP-Free IV Containers, and DUPLEX* Drug
Delivery System.
"Through our partnership with Premier, we will have the ability to reach
their more than 1,500 hospitals and healthcare facilities in the United
States," said Caroll H. Neubauer, chairman and CEO of B.
Braun Medical Inc. "We are confident that Premier members will benefit from
access to our infusion products, which are designed to enhance both
clinician and patient safety."
"In addition to B. Braun gaining access to 1,500 of the nation's leading
health institutions and systems, Premier alliance participants will be able
to tap into our global knowledge in drug-administration safety," said Manny
Losada, senior vice president of sales for B. Braun Medical Inc. "By
evaluating our full-line of infusion products, hospital staff can learn more
about how technology can help supplement training, address nursing shortages
while providing adherence to best-practice procedures...all with a goal to
reduce medical errors."
Source: B. Braun
Second Strain of Bird Flu Found in US Dairy Cows: What It Means for Infection Prevention and Control
February 7th 2025A new H5N1 strain was found in Nevada dairy cows, challenging earlier transmission theories. This raises concerns about animal vulnerability, human health risks, and food safety. Experts emphasize the need for improved surveillance, biosecurity, and cross-sector collaboration to contain the virus spread.
Fungal Infections: The Silent Epidemic Threatening Global Health
February 6th 2025Fungal infections are a rising global threat, with antifungal resistance complicating treatment. Neil J. Clancy, MD, emphasizes the urgent need for research, better diagnostics, and stronger infection prevention strategies.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
Clean Hospitals With Alexandra Peters, PhD: The Double-Edged Sword of High-Tech
January 30th 2025Despite revolutionary advancements like alcohol-based hand rubs, infection prevention still faces major hurdles. Poor adherence to hygiene, overreliance on technology, and understaffed environmental services create perfect storm conditions for deadly outbreaks.